On 1 June 2021, the Amended Patent Law took effect and introduced patent term extension (PTE) and patent linkage (PL) which are closely related to the pharmaceutical industry. The legislative amendment reflects China's determination to promote the research and development of innovative drugs in the pharmaceutical industry. The China National Intellectual Property Administration (CNIPA), the National Medical Products Administration (NMPA) and the Supreme People's Court (SPC) recently issued further rules to complete the establishment of PL system. As for PTE, as the amended Implementing Rules of the Patent Law (Amended Implementing Rules) have not been issued yet, the CNIPA issued some temporary measures to address the issue. Continue Reading
Monday, August 2 2021 \ Published by Kluwer Patent Blog.